Dezhan HealthCare Co Ltd
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathi… Read more
Dezhan HealthCare Co Ltd (000813) - Total Liabilities
Latest total liabilities as of September 2025: CN¥271.09 Million CNY
Based on the latest financial reports, Dezhan HealthCare Co Ltd (000813) has total liabilities worth CN¥271.09 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Dezhan HealthCare Co Ltd - Total Liabilities Trend (1995–2024)
This chart illustrates how Dezhan HealthCare Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Dezhan HealthCare Co Ltd Competitors by Total Liabilities
The table below lists competitors of Dezhan HealthCare Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hatsun Agro Product Limited
NSE:HATSUN
|
India | ₹26.00 Billion |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA
|
India | ₹69.50 Billion |
|
BIEM.L .FDLKK Garment Co Ltd
SHE:002832
|
China | CN¥1.89 Billion |
|
Haian Rubber Grp Co Ltd
SHE:001233
|
China | CN¥869.60 Million |
|
Jiangxi Bestoo Energy Co Ltd
SHE:001376
|
China | CN¥514.95 Million |
|
Jyoti CNC Automation Limited
NSE:JYOTICNC
|
India | ₹12.67 Billion |
|
Ulker Biskuvi Sanayi AS
IS:ULKER
|
Turkey | TL86.63 Billion |
Liability Composition Analysis (1995–2024)
This chart breaks down Dezhan HealthCare Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 28.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dezhan HealthCare Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dezhan HealthCare Co Ltd (1995–2024)
The table below shows the annual total liabilities of Dezhan HealthCare Co Ltd from 1995 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥154.88 Million | +12.93% |
| 2023-12-31 | CN¥137.15 Million | -64.87% |
| 2022-12-31 | CN¥390.38 Million | +26.73% |
| 2021-12-31 | CN¥308.05 Million | -30.99% |
| 2020-12-31 | CN¥446.37 Million | +41.19% |
| 2019-12-31 | CN¥316.15 Million | -50.61% |
| 2018-12-31 | CN¥640.15 Million | +7.85% |
| 2017-12-31 | CN¥593.57 Million | +238.46% |
| 2016-12-31 | CN¥175.37 Million | -70.74% |
| 2015-12-31 | CN¥599.40 Million | -11.82% |
| 2014-12-31 | CN¥679.75 Million | +38.59% |
| 2013-12-31 | CN¥490.48 Million | +173.19% |
| 2012-12-31 | CN¥179.54 Million | -25.16% |
| 2011-12-31 | CN¥239.89 Million | +12.07% |
| 2010-12-31 | CN¥214.05 Million | +130.97% |
| 2009-12-31 | CN¥92.67 Million | +46.88% |
| 2008-12-31 | CN¥63.09 Million | -47.81% |
| 2007-12-31 | CN¥120.89 Million | -4.91% |
| 2006-12-31 | CN¥127.13 Million | -52.93% |
| 2005-12-31 | CN¥270.09 Million | -37.43% |
| 2004-12-31 | CN¥431.68 Million | -25.95% |
| 2003-12-31 | CN¥582.97 Million | +6.50% |
| 2002-12-31 | CN¥547.41 Million | -3.40% |
| 2001-12-31 | CN¥566.67 Million | -19.87% |
| 2000-12-31 | CN¥707.22 Million | +39.71% |
| 1999-12-31 | CN¥506.21 Million | -1.78% |
| 1998-12-31 | CN¥515.39 Million | -31.46% |
| 1997-12-31 | CN¥751.97 Million | +13.28% |
| 1996-12-31 | CN¥663.82 Million | +0.29% |
| 1995-12-31 | CN¥661.93 Million | -- |